AnodyneWiki

Harmaline

Harmaline
Harmaline
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass214.26 g/mol [1]
AppearanceOrthorhombic bipyramidal prisms, tablets from methanol, rhombic octahedra from ethanol [1]
Melting point229-231 °C [1]
SolubilitySlightly soluble in water, alcohol, ether; quite soluble in hot alcohol, dilute acids [1]
Predicted LogP2.1 [1]
Structural Identifiers
[]
Molecular formulaC13H14N2O
IUPAC name7-methoxy-1-methyl-4,9-dihydro-3H-pyrido[3,4-b]indole
SMILESCC1=NCCC2=C1NC3=C2C=CC(=C3)OC
InChIInChI=1S/C13H14N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-4,7,15H,5-6H2,1-2H3
InChIKeyRERZNCLIYCABFS-UHFFFAOYSA-N
CAS number304-21-2
UNIICN58I4TOET
PubChem CID3564
Pharmacokinetics[]
OnsetOral: 1–2 hours, Intravenous injection: Seconds
Elimination half-life2 hours
Duration of actionOral: 5–8 hours, Intravenous injection: "Much shorter" (than oral)
Routes of administrationOral, intravenous

Harmaline (also known as Dihydroharmine, Harmidine, Armalin, 3,4-Dihydroharmine, O-Methylharmalol, Harmalol methyl ether, 3H-Pyrido[3,4-b]indole, 4,9-dihydro-7-methoxy-1-methyl-, 1-Methyl-7-methoxy-3,4-dihydro-β-carboline, 4,9-Dihydro-7-methoxy-1-methyl-3H-pyrido(3,4-b)indole or 3H-Pyrido(3,4-b)indole, 4,9-dihydro-7-methoxy-1-methyl-) is a substance of the β-carboline class.

It is a constituent of tobacco.

Chemistry

 []

Harmaline is achiral.

Harmaline matches Lipinski's rule of five.

There are currently 6 reagent-interactions on

ReagentColor changeDescription
Marquisorange > brown
Meckebrown > dark green
Mandelinbrown > black
Simon'sno blue color change
Ehrlichyellow
Hofmannyellow

Pharmacology

Mechanism of action []

Three psychological active principles from the seeds of Peganum harmala L., harmine, harmaline and harmalol, showed vasorelaxant activities in isolated rat thoracic aorta preparations precontracted by phenylephrine or KCl with rank order of relaxation potency of harmine > harmaline > harmalol. The vasorelaxant effects of harmine and harmaline (but not harmalol) were attenuated by endothelium removal or pretreatment with a nitric oxide (NO) synthase Nomega-nitro-L-arginine methyl ester. In cultured rat aortic endothelial cells, harmine and harmaline (but not harmalol) increased NO release, which was dependent on the presence of external Ca2+. In endothelium-denuded preparations, pretreatment of harmine, harmaline or harmalol (3-30 microM) inhibited phenylephrine-induced contractions in a non-competitive manner. Receptor binding assays indicated that all 3 compounds interacted with cardiac alpha1-adrenoceptors with comparable affinities (Ki value around 31 - 36 microM), but only harmine weakly interacted with the cardiac 1,4-dihydropyridine binding site of L-type Ca2+ channels (Ki value of 408 microM). Therefore, the present results suggested that the vasorelaxant effects of harmine and harmaline are attributed to their actions on the endothelial cells to release NO and on the vascular smooth muscles to inhibit the contractions induced by the activation of receptor-linked and voltage-dependent Ca2+ channels. The vasorelaxant effect of harmalol was not endothelium-dependent. [1]

Experience reports

Erowid

There are currently 11 experience reports involving harmaline on : []

Reddit

There are currently 4 trip reports involving harmaline on : []

 []

  • Australia: Harmaline is a Schedule 9.
  • Canada: Harmaline is a Schedule III.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 3564, Harmaline. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/3564
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Harmaline. UNII: CN58I4TOET. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/CN58I4TOET

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 09:11:32
drugsprook2026-11-20 09:11:28
erowidok2026-11-20 09:11:30
gsrsok2026-11-20 09:11:28
hmdbmissing (hmdb.ca refused automated access to HMDB0030310)2026-11-20 09:11:28
keggmissing (no KEGG DRUG entry)2026-11-20 09:11:31
pubchemok2026-11-20 09:11:28
redditok2026-11-20 09:11:28
sidermissing (not in SIDER)2026-11-20 09:11:28
structureok2026-11-20 09:11:28
wikipediaok2026-11-20 09:11:28